Skip to Content

Cefuroxime Sodium Injection

Last Updated: December 1, 2018
Status: Current

Products Affected - Description
    • Cefuroxime powder for solution for injection, Hikma, 1.5 gram, vial, 25 count, NDC 00143-9977-22
    • Cefuroxime powder for solution for injection, Hikma, 750 mg, vial, 25 count, NDC 00143-9979-22
    • Cefuroxime powder for solution for injection, Sagent, 1.5 gram, vial, 25 count, NDC 25021-0119-20
    • Cefuroxime powder for solution for injection, Sagent, 750 mg, vial, 25 count, NDC 25021-0118-10
Reason for the Shortage
    • Sagent has cefuroxime injection on shortage due to manufacturing delays.
    • Teligent discontinued all Zinacef presentations in February 2018.
    • Hikma did not provide a reason for the cefuroxime injection shortage. They are not currently marketing the 7.5 gram vials.
Available Products
    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Sagent has cefuroxime 750 mg vials on back order and the company estimates a release date of January 2019. The 1.5 gram vials are on allocation.
    • Hikma has cefuroxime 750 mg vials on back order and the company estimates a release date of mid- to late-December 2018. The 1.5 gram vials are on back order and the company cannot estimate a release date.

Updated

Updated December 1, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 25, 2013 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide